DVAX Stock Forecast: Table Is Being Set – Revenue Growth Is On The Way

  The article was written by Amber Zhou, a Financial Analyst at I Know First.

DVAX Stock Forecast

“We believe there’s a great opportunity for Dynavax to contribute to the overall health of the adult population with diabetes”—said Dr. Rob Janssen, chief medical officer of Dynavax.

(Source: mmm-online.com)

 

Highlights:

  • Competitive Edge and Huge Market Potential from Heplisav-B®
  • Market Doubts about Trial Data of Immuno-Oncology Platform
  • Strong Cash Position from Debt Financing
  • Current I Know First Bullish Forecast For DVAX

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

GILD Stock Forecast: 2Q Results & DD Analysis

This article was written by Anna Latini, a Financial Analyst at I Know First

GILD Stock Forecast

Summary: 
  • Q2 Results Beat Estimates
  • GILD Remains A Solid Income Generating Stock
  • Discount Dividend Model Analysis
  • I Know First Is Bullish on GILD

Outlook For Gold PricesRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content Here

Quick Win by the Algorithm: Trial Development Pushes ARRY Stock Higher

Biopharm Stock Prediction: KERX Developing New Ways to Treat Patients With CKD

This article was written by Blair Goldenberg, a Financial Analyst at I Know First, and enrolled in a Masters of Finance at Colorado State University.

Biopharm Stock Prediction

Summary
  • Background on Keryx Biopharmaceuticals (KERX)
  • KERX Stock Analysis
  • KERX Helping Patients Around the US
  • I Know First Algorithm Bullish Forecast For KERX

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

Quick Win by the Algorithm: PTN Up Due to Development of New Drug